Clinical Oncology Next Generation Sequencing Market - Global Outlook and Forecast 2021-2027

March 2021 | 106 pages | ID: C2CC39A53EC7EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Clinical Oncology Next Generation Sequencing in Global, including the following market information:

Global Clinical Oncology Next Generation Sequencing Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Clinical Oncology Next Generation Sequencing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Oncology Next Generation Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clinical Oncology Next Generation Sequencing Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Clinical Oncology Next Generation Sequencing Market Segment Percentages, By Type, 2020 (%)

• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing Centrifuges

China Clinical Oncology Next Generation Sequencing Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Clinical Oncology Next Generation Sequencing Market Segment Percentages, By Application, 2020 (%)

• Hospitals
• Clinics
• Laboratories

Global Clinical Oncology Next Generation Sequencing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Clinical Oncology Next Generation Sequencing Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Clinical Oncology Next Generation Sequencing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Clinical Oncology Next Generation Sequencing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Illumina, Inc.
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies
• Myriad Genetics
• Beijing Genomics Institute (BGI)
• Perkin Elmer
• Foundation Medicine
• Pacific Bioscience
• Oxford Nanopore Technologies Ltd.
• Paradigm Diagnostics
• Caris Life Sciences
• Partek, Inc.
• Eurofins Scientific S.E.
• Qiagen N.V.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Clinical Oncology Next Generation Sequencing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Clinical Oncology Next Generation Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING OVERALL MARKET SIZE

2.1 Global Clinical Oncology Next Generation Sequencing Market Size: 2021 VS 2027
2.2 Global Clinical Oncology Next Generation Sequencing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Clinical Oncology Next Generation Sequencing Players in Global Market
3.2 Top Global Clinical Oncology Next Generation Sequencing Companies Ranked by Revenue
3.3 Global Clinical Oncology Next Generation Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Clinical Oncology Next Generation Sequencing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Clinical Oncology Next Generation Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Oncology Next Generation Sequencing Players in Global Market
  3.6.1 List of Global Tier 1 Clinical Oncology Next Generation Sequencing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Clinical Oncology Next Generation Sequencing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Clinical Oncology Next Generation Sequencing Market Size Markets, 2021 & 2027
  4.1.2 Whole Genome Sequencing
  4.1.3 Whole Exome Sequencing
  4.1.4 Targeted Sequencing & Resequencing Centrifuges
4.2 By Type - Global Clinical Oncology Next Generation Sequencing Revenue & Forecasts
  4.2.1 By Type - Global Clinical Oncology Next Generation Sequencing Revenue, 2016-2021
  4.2.2 By Type - Global Clinical Oncology Next Generation Sequencing Revenue, 2022-2027
  4.2.3 By Type - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Clinical Oncology Next Generation Sequencing Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Laboratories
5.2 By Application - Global Clinical Oncology Next Generation Sequencing Revenue & Forecasts
  5.2.1 By Application - Global Clinical Oncology Next Generation Sequencing Revenue, 2016-2021
  5.2.2 By Application - Global Clinical Oncology Next Generation Sequencing Revenue, 2022-2027
  5.2.3 By Application - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Clinical Oncology Next Generation Sequencing Market Size, 2021 & 2027
6.2 By Region - Global Clinical Oncology Next Generation Sequencing Revenue & Forecasts
  6.2.1 By Region - Global Clinical Oncology Next Generation Sequencing Revenue, 2016-2021
  6.2.2 By Region - Global Clinical Oncology Next Generation Sequencing Revenue, 2022-2027
  6.2.3 By Region - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
  6.3.2 US Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.3.3 Canada Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.3.4 Mexico Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
  6.4.2 Germany Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.4.3 France Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.4.4 U.K. Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.4.5 Italy Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.4.6 Russia Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.4.7 Nordic Countries Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.4.8 Benelux Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
  6.5.2 China Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.5.3 Japan Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.5.4 South Korea Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.5.5 Southeast Asia Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.5.6 India Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
  6.6.2 Brazil Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.6.3 Argentina Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
  6.7.2 Turkey Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.7.3 Israel Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.7.4 Saudi Arabia Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
  6.7.5 UAE Clinical Oncology Next Generation Sequencing Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Illumina, Inc.
  7.1.1 Illumina, Inc. Corporate Summary
  7.1.2 Illumina, Inc. Business Overview
  7.1.3 Illumina, Inc. Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.1.4 Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.1.5 Illumina, Inc. Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.2.4 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.2.5 Thermo Fisher Scientific Key News
7.3 F. Hoffmann-La Roche Ltd.
  7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Agilent Technologies
  7.4.1 Agilent Technologies Corporate Summary
  7.4.2 Agilent Technologies Business Overview
  7.4.3 Agilent Technologies Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.4.4 Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.4.5 Agilent Technologies Key News
7.5 Myriad Genetics
  7.5.1 Myriad Genetics Corporate Summary
  7.5.2 Myriad Genetics Business Overview
  7.5.3 Myriad Genetics Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.5.4 Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.5.5 Myriad Genetics Key News
7.6 Beijing Genomics Institute (BGI)
  7.6.1 Beijing Genomics Institute (BGI) Corporate Summary
  7.6.2 Beijing Genomics Institute (BGI) Business Overview
  7.6.3 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.6.4 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.6.5 Beijing Genomics Institute (BGI) Key News
7.7 Perkin Elmer
  7.7.1 Perkin Elmer Corporate Summary
  7.7.2 Perkin Elmer Business Overview
  7.7.3 Perkin Elmer Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.4.4 Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.7.5 Perkin Elmer Key News
7.8 Foundation Medicine
  7.8.1 Foundation Medicine Corporate Summary
  7.8.2 Foundation Medicine Business Overview
  7.8.3 Foundation Medicine Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.8.4 Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.8.5 Foundation Medicine Key News
7.9 Pacific Bioscience
  7.9.1 Pacific Bioscience Corporate Summary
  7.9.2 Pacific Bioscience Business Overview
  7.9.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.9.4 Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.9.5 Pacific Bioscience Key News
7.10 Oxford Nanopore Technologies Ltd.
  7.10.1 Oxford Nanopore Technologies Ltd. Corporate Summary
  7.10.2 Oxford Nanopore Technologies Ltd. Business Overview
  7.10.3 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.10.4 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.10.5 Oxford Nanopore Technologies Ltd. Key News
7.11 Paradigm Diagnostics
  7.11.1 Paradigm Diagnostics Corporate Summary
  7.11.2 Paradigm Diagnostics Business Overview
  7.11.3 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.11.4 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.11.5 Paradigm Diagnostics Key News
7.12 Caris Life Sciences
  7.12.1 Caris Life Sciences Corporate Summary
  7.12.2 Caris Life Sciences Business Overview
  7.12.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.12.4 Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.12.5 Caris Life Sciences Key News
7.13 Partek, Inc.
  7.13.1 Partek, Inc. Corporate Summary
  7.13.2 Partek, Inc. Business Overview
  7.13.3 Partek, Inc. Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.13.4 Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.13.5 Partek, Inc. Key News
7.14 Eurofins Scientific S.E.
  7.14.1 Eurofins Scientific S.E. Corporate Summary
  7.14.2 Eurofins Scientific S.E. Business Overview
  7.14.3 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.14.4 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.14.5 Eurofins Scientific S.E. Key News
7.15 Qiagen N.V.
  7.15.1 Qiagen N.V. Corporate Summary
  7.15.2 Qiagen N.V. Business Overview
  7.15.3 Qiagen N.V. Clinical Oncology Next Generation Sequencing Major Product Offerings
  7.15.4 Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
  7.15.5 Qiagen N.V. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Clinical Oncology Next Generation Sequencing Market Opportunities & Trends in Global Market
Table 2. Clinical Oncology Next Generation Sequencing Market Drivers in Global Market
Table 3. Clinical Oncology Next Generation Sequencing Market Restraints in Global Market
Table 4. Key Players of Clinical Oncology Next Generation Sequencing in Global Market
Table 5. Top Clinical Oncology Next Generation Sequencing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Clinical Oncology Next Generation Sequencing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Clinical Oncology Next Generation Sequencing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Clinical Oncology Next Generation Sequencing Product Type
Table 9. List of Global Tier 1 Clinical Oncology Next Generation Sequencing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clinical Oncology Next Generation Sequencing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Clinical Oncology Next Generation Sequencing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Clinical Oncology Next Generation Sequencing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Clinical Oncology Next Generation Sequencing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Clinical Oncology Next Generation Sequencing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2022-2027
Table 30. Illumina, Inc. Corporate Summary
Table 31. Illumina, Inc. Clinical Oncology Next Generation Sequencing Product Offerings
Table 32. Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product Offerings
Table 35. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 36. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product Offerings
Table 38. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies Clinical Oncology Next Generation Sequencing Product Offerings
Table 41. Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 42. Myriad Genetics Corporate Summary
Table 43. Myriad Genetics Clinical Oncology Next Generation Sequencing Product Offerings
Table 44. Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 45. Beijing Genomics Institute (BGI) Corporate Summary
Table 46. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product Offerings
Table 47. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 48. Perkin Elmer Corporate Summary
Table 49. Perkin Elmer Clinical Oncology Next Generation Sequencing Product Offerings
Table 50. Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 51. Foundation Medicine Corporate Summary
Table 52. Foundation Medicine Clinical Oncology Next Generation Sequencing Product Offerings
Table 53. Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 54. Pacific Bioscience Corporate Summary
Table 55. Pacific Bioscience Clinical Oncology Next Generation Sequencing Product Offerings
Table 56. Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 57. Oxford Nanopore Technologies Ltd. Corporate Summary
Table 58. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product Offerings
Table 59. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 60. Paradigm Diagnostics Corporate Summary
Table 61. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product Offerings
Table 62. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 63. Caris Life Sciences Corporate Summary
Table 64. Caris Life Sciences Clinical Oncology Next Generation Sequencing Product Offerings
Table 65. Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 66. Partek, Inc. Corporate Summary
Table 67. Partek, Inc. Clinical Oncology Next Generation Sequencing Product Offerings
Table 68. Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 69. Eurofins Scientific S.E. Corporate Summary
Table 70. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product Offerings
Table 71. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)
Table 72. Qiagen N.V. Corporate Summary
Table 73. Qiagen N.V. Clinical Oncology Next Generation Sequencing Product Offerings
Table 74. Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Clinical Oncology Next Generation Sequencing Segment by Type
Figure 2. Clinical Oncology Next Generation Sequencing Segment by Application
Figure 3. Global Clinical Oncology Next Generation Sequencing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Clinical Oncology Next Generation Sequencing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Clinical Oncology Next Generation Sequencing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clinical Oncology Next Generation Sequencing Revenue in 2020
Figure 8. By Type - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 12. US Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 16. Germany Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 17. France Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 24. China Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 28. India Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 30. Brazil Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
Figure 33. Turkey Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Clinical Oncology Next Generation Sequencing Revenue, (US$, Mn), 2016-2027
Figure 37. Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)